2021-01-11,ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2021
2021-01-05,ALX Oncology to Present at 39th Annual J.P. Morgan Healthcare Conference
2020-12-17,ALX Oncology Added to the NASDAQ Biotechnology Index
2020-12-14,ALX Oncology Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares
2020-12-11,Is ALXO A Good Stock To Buy Now?
2020-12-09,ALX Oncology Announces Pricing of Upsized Public Offering of Common Stock
2020-12-07,ALX Oncology Announces Proposed Public Offering of Common Stock
2020-12-07,"ALX Oncology Announces Updated Data from ASPEN-01, the Ongoing Phase 1b Study of ALX148, Showing Robust, Durable Activity in Patients with Non-Hodgkin Lymphoma"
2020-12-07,ALX Oncology Announces Updates on Planned ALX148 Phase 2 Head and Neck Cancer Studies
2020-11-24,ALX Oncology Announces December 2020 Virtual Investor Conference Participation
2020-11-12,ALX Oncology Reports Third Quarter 2020 Financial Results and Provides Clinical Development and Operational Highlights
2020-11-09,"ALX Oncology Announces New Data from ASPEN-01, the Phase 1b Study of ALX148, Showing Promising Initial Clinical Responses in Patients with Advanced Solid Tumors"
2020-11-05,ALX Oncology to Present ALX148 Clinical Data at the 62nd American Society of Hematology (ASH) Annual Meeting
2020-11-02,ALX Oncology Announces November 2020 Virtual Investor Conference Participation
2020-10-28,"ALX Oncology Announces First Patient Dosed in ASPEN-02, a Phase 1/2 Study of ALX148 in Combination with Azacitidine in Patients with Myelodysplastic Syndrome"
2020-10-14,ALX Oncology to Present ALX148 Clinical Data at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
2020-10-06,ALX Oncology Names Leading Oncology Experts to Scientific Advisory Board
2020-09-22,"ALX Oncology to Collaborate with Merck on Phase 2 Immuno-Oncology Studies Evaluating ALX148, Targeting CD47, in Combination with KEYTRUDA® (pembrolizumab) in Patients with Head & Neck Cancer"
2020-09-17,ALX Oncology Added to Russell 2000® and 3000® Indexes
2020-09-08,ALX Oncology Announces Participation at Upcoming Investor Conferences
2020-08-27,ALX Oncology Reports Second Quarter 2020 Financial Results and Provides Operational and Clinical Highlights
2020-07-21,ALX Oncology Announces Closing of Initial Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares
2020-07-17,Berkeley Lights IPO Jumps By Triple Digits As Hot Biotech Begins Trading
